Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Non-Current Liabilities: 2018-2025

Historic Other Non-Current Liabilities for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to $427,000.

  • Neurogene's Other Non-Current Liabilities fell 33.90% to $427,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $427,000, marking a year-over-year decrease of 33.90%. This contributed to the annual value of $718,000 for FY2024, which is 28.63% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Other Non-Current Liabilities is $427,000, which was down 42.14% from $738,000 recorded in Q2 2025.
  • Neurogene's Other Non-Current Liabilities' 5-year high stood at $1.0 million during Q4 2023, with a 5-year trough of $427,000 in Q3 2025.
  • In the last 3 years, Neurogene's Other Non-Current Liabilities had a median value of $728,000 in 2024 and averaged $730,875.
  • Data for Neurogene's Other Non-Current Liabilities shows a peak YoY increase of 2.93% (in 2025) and a maximum YoY decrease of 33.90% (in 2025) over the last 5 years.
  • Over the past 3 years, Neurogene's Other Non-Current Liabilities (Quarterly) stood at $1.0 million in 2023, then declined by 28.63% to $718,000 in 2024, then crashed by 33.90% to $427,000 in 2025.
  • Its Other Non-Current Liabilities was $427,000 in Q3 2025, compared to $738,000 in Q2 2025 and $738,000 in Q1 2025.